Boundless Bio, founded in 2018, is a biopharmaceutical company that develops novel cancer therapeutics seeking to understand and treat intractable cancers. Boundless Bio aims to interrogate extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio is headquartered in La Jolla, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/16/2023 | Series C | $100MM | $xx.xx | $273.76MM | Bayer, Healthcare Capital, Piper Heartland, Ra Capital Management, Sectoral Asset Management | |
Price per Share
$xx.xx
Shares Outstanding
142,857,138
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bayer, Healthcare Capital, Piper Heartland, Ra Capital Management, Sectoral Asset Management
|
||||||
04/28/2021 | Series B | $105.59MM | $xx.xx | $262.52MM | Alexandria Venture Investments, Arch Venture Partners, Boxer Capital, City Hill Ventures, Fidelity, Gt Healthcare Capital Partners, Logos Capital, Nextech, Pfm Health Sciences, Ra Capital Management, Redmile Group, Surveyor Capital, Vertex Ventures Hc, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
78,211,116
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Arch Venture Partners, Boxer Capital, City Hill Ventures, Fidelity, Gt Healthcare Capital Partners, Logos Capital, Nextech, Pfm Health Sciences, Ra Capital Management, Redmile Group, Surveyor Capital, Vertex Ventures Hc, Wellington Management
|
||||||
09/19/2019 | Series A | $46.47MM | $xx.xx | $103.26MM | Alexandria Venture Investments, Arch Venture Partners, Boxer Capital, City Hill Ventures, Gt Healthcare Capital Partners, Vertex Ventures | |
Price per Share
$xx.xx
Shares Outstanding
66,378,590
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Arch Venture Partners, Boxer Capital, City Hill Ventures, Gt Healthcare Capital Partners, Vertex Ventures
|